Gonadotropin levels in women with polycystic ovary syndrome: Their relationship to body weight and insulin levels

Journal of Endocrinological Investigation

Volumn 19, Issue 3, 1996, Pages 139-145

  Tropeano, G ^a   Vuolo, I P ^a   Lucisano, A ^a   Liberale, I ^a   Barini, A ^a   Carfagna, P ^a   Caroli, G ^a   Menini, E ^a   Dell'Acqua, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Androgens; Body weight; Insulin resistance; PCOS; Plasma gonadotropins

Indexed keywords

C PEPTIDE; FOLLITROPIN; GONADORELIN; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE;

EID: 0029943227     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349856     Document Type: Article

References (19)

1. Conway G.S., Honour J.W., Jacobs H.S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound feature in 556 patients. Clin. Endocrinol. (Oxf.) 30:459, 1989.
2. Conway S.G., Jacobs H.S., Holly J.M.P., Wass J.A.M. Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 33:593, 1990.
3. Kiddy D.S., Sharp P.S., White D.M., Scanlon M.F., Mason H.D., Bracy C.S. Differences in clinical and endocrine features between obese and non obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. (Oxf.) 32:213, 1990.
4. Daniel S.G., Kistner R.W., Ryan K.S. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62: 904, 1986.
5. Anttilla L., Ding Y-A., Ruutiainen K., Erkkola R., Irjala K., Huhtaniemi I. Clinical features and circulating gonadotropin insulin and androgen interactions in women with polycystic ovarian disease. Fertil. Steril. 55: 1057, 1991.
6. Dale P.O., Tanbo T., Vaaler S., Abyholm T. Body weight, hyperinsulinemia and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril. 58:487, 1992.
7. Dunaif A., Mandeli J., Fluhr H., Dobriansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 66: 131, 1988.
8. Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 37:87, 1989.
9. Nestler J.E., Clore J.N., Blackard W.G. The central role of obesity (o hyperinsulinemia) in the pathogenesis of the polycistic ovary syndrome. Am. J. Obstet. Gynecol. 161: 1095, 1989.
10. Tropeano G., Lucisano A., Liberale I., Barini A., Vuolo I.P., Martino G., Menini E., Dell'Acqua S. Insulin, C-peptide, androgens and Beta-Endorphin response to oral glucose in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 78: 305, 1994.
11. Ardaens Y., Robert Y., Le Maitre L., Fossati P., Dewailly D. Polycystic ovarian disease: contribution of vaginal endosonography and reassesment of ultrasonic diagnosis. Fertil. Steril. 55: 1062, 1991.
12. Goldzieher J.W., Dozier I.S., Smith K.D., Steinberg E.J. Improving the diagnostic reliability of rapidly fluctuating plasma-hormone levels by optimized multiple-samply techniques. J. Clin. Endocrinol. Metab. 43:824, 1976.
13. Rebar R., Judd H.L., Yen S.S.C., Rakoff J., Vandenberg G., Naftolin B. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57: 1320, 1976.
14. Dunaif A., Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J. Clin. Invest. 83:23, 1989.
15. Anttila L., Koskinen P., Jaatinen T-A., Erkkola R.. Irjala K., Ruutiainen K. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum. Reprod. 8: 1179, 1993.
16. Polonsky K.S., Given B.D., Hirsch L. Quantitative study of insulin secretion and clearance in normal and obese subjects. J. Clin. Invest. 81: 435, 1988.
17. Buyalos R.P., Geffner M.E., Watanabe R.M., Bergaman R.N., Gornbein J.A., Judd H.L. The influence of luteinizing hormone and insulin on sex steroid and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertil. Steril. 60:626, 1993.
18. Peiris A.N., Mueller R.A., Struve M.F., Smith G.A., Kissebah A.H. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. J. Clin. Endocrinol. Metab. 64: 162, 1987.
19. Adashi E.Y., Hsueh A.J.W., Yen S.S.C. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 708: 1441, 1981.